Revolution Medicines (RVMD) Non-cash Items (2018 - 2026)

Revolution Medicines' Non-cash Items history runs 9 years deep, the most recent figure standing at $288.0 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 60.36% year-over-year to $288.0 million; the TTM figure through Mar 2026 stood at $288.0 million (up 60.36% YoY), while the FY2025 annual figure was $885.5 million, up 220.44% from the prior year.
• Non-cash Items was $288.0 million for Q1 2026 at Revolution Medicines, down from $885.5 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $885.5 million in Q4 2025 to a low of $52.8 million in Q3 2022.
• Historically, Non-cash Items has averaged $174.6 million across 5 years, with a median of $118.7 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Non-cash Items increased 1.46% in 2022, then soared 220.44% in 2025.
• A 5-year view of Non-cash Items shows it stood at $85.2 million in 2022, then soared by 35.02% to $115.0 million in 2023, then jumped by 140.27% to $276.3 million in 2024, then jumped by 220.44% to $885.5 million in 2025, then plunged by 67.48% to $288.0 million in 2026.
• The last three Non-cash Items figures came in at $288.0 million (Q1 2026), $885.5 million (Q4 2025), and $177.7 million (Q3 2025), per Business Quant data.